[Experiences with the new spasmo-analgetic benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate in combination with the analgetic metamizol in a clinical department].
D000328:Adult; D000632:Aminopyrine / Q000627:therapeutic use*; D001561:Benzilates / Q000627:therapeutic use*; D003085:Colic / Q000188:drug therapy; D004357:Drug Synergism; D005260:Female; D005705:Gallbladder Diseases / Q000188:drug therapy; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use*; D013035:Spasm / Q000188:drug therapy*; D014570:Urologic Diseases / Q000188:drug therapy
D001561:Benzilates; D010880:Piperidines; D000632:Aminopyrine
Erfahrungen mit dem neuen Spasmo-Analgeticum Benzilsäure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat in Verbindung mit dem Analgeticum Metamizol auf einer internen Abteilung.